Idalopirdine Hydrochloride

CAS No. 467458-02-2

Idalopirdine Hydrochloride( Lu AE58054 Hydrochloride | Idalopirdine hydrochloride | Idalopirdine HCl )

Catalog No. M27650 CAS No. 467458-02-2

Lu AE58054 hydrochloride is an in-vivo binding affinity and effect, in-vitro selectivity and potency of 5-HT(6)R antagonist (Ki: 0.83 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 85 In Stock
5MG 79 In Stock
10MG 113 In Stock
25MG 198 In Stock
50MG 290 In Stock
100MG 410 In Stock
200MG 551 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Idalopirdine Hydrochloride
  • Note
    Research use only, not for human use.
  • Brief Description
    Lu AE58054 hydrochloride is an in-vivo binding affinity and effect, in-vitro selectivity and potency of 5-HT(6)R antagonist (Ki: 0.83 nM).
  • Description
    Lu AE58054 hydrochloride is an in-vivo binding affinity and effect, in-vitro selectivity and potency of 5-HT(6)R antagonist (Ki: 0.83 nM).(In Vitro):In the 5-HT(6) GTP gamma S efficacy assay, Lu AE58054 showed potent inhibition of 5-HT-mediated activation. Apart from medium affinity to adrenergic alpha (1B)- and alpha(1A)-adrenoreceptors, Lu AE58054 shows >50-fold selectivity compared with more than 70 targets examined.(In Vivo):In the rats model, Orally administered Lu AE58054 inhibited binding of the 5-HT6 antagonist Lu AE60157 (ED50: 2.7 mg/kg). Administration of Lu AE58054 in a dose range (5–20 mg/kg) leading to above 65% 5-HT6R binding, which reversed cognitive impairment in rats treatment with phencyclidine. These results indicate that Lu AE58054 is a potent antagonist of 5-HT6Rs with good oral bioavailability in the rat model of cognitive impairment in schizophrenia.
  • In Vitro
    ——
  • In Vivo
    Idalopirdine (intraperitoneal injection, 5?mg/kg, daily, 28 days) Hydrochloride can reduce food intake and body weight in over-eating rat models.Idalopirdine (1 or 2?mg/kg, i.v) Hydrochloride can dose-dependently increase the gamma power during nPO electrical stimulation, enhance effect of donepezil on cortical gamma oscillations but no alteration of sleep-wake patterns in rats. Animal Model:Male Wistar rats Dosage:5?mg/kg Administration:intraperitoneal injection, daily, 28 days Result:Significantly reduced the amount of calories consumed by animals in a palatable diet and significantly reduced plasma levels of glucose, triglycerides and cholesterol.Animal Model:Male Sprague-Dawley rats Dosage:1 or 2?mg/kg Administration:i.v.Result:No significant increase in the gamma power at 1 mg/kg and significantly increased the gamma power at 2 mg/kg.Significantly enhanced and/or prolonged effect of low-dose donepezil (0.3 mg/kg) on gamma power during 60-minute nPO stimulation after donepezil administration.
  • Synonyms
    Lu AE58054 Hydrochloride | Idalopirdine hydrochloride | Idalopirdine HCl
  • Pathway
    Endocrinology/Hormones
  • Target
    5-HT Receptor
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    467458-02-2
  • Formula Weight
    434.84
  • Molecular Formula
    C20H20ClF5N2O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : ≥ 25 mg/mL (57.49 mM)
  • SMILES
    Cl.FC(F)C(F)(F)COc1cccc(CNCCc2c[nH]c3cc(F)ccc23)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lux G, R?sch W. [Conservative treatment of gastric ulcer]. Med Klin. 1980 Aug 29;75(18):638-44. Review. German.
molnova catalog
related products
  • Trazodone

    Trazodone, a 5-HT 2A/2C receptor antagonist, is used as an antidepressant for treating major anxiety disorders and depressive disorder.

  • Ritanserin

    Ritanserin is a highly effective, relatively selective, long-acting antagonist of 5-HT2 receptor (IC50: 0.9 nM), less active on Histamine H1, Dopamine D2, Adrenergic α1, Adrenergic α2 receptors.

  • Gamabufotalin

    Gamabufotalin, a major bufadienolide of Chansu, has been used for treatment of COX-2-mediated diseases and cancer therapy due to its desirable metabolic stability and less adverse effect.